ClearPoint Neuro (CLPT) EPS (Basic) (2011 - 2026)

ClearPoint Neuro has disclosed EPS (Basic) across 15 years of filings, most recently posting -$0.32 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at -$0.32, down 45.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.01 (down 32.89% YoY), and the FY2025 annual result was -$0.9, down 28.57% from the prior year.
• EPS (Basic) came in at -$0.32 for Q1 2026 at ClearPoint Neuro, down from -$0.27 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of -$0.15 in Q3 2022 to a low of -$0.32 in Q1 2026.
• The 5-year median for EPS (Basic) is -$0.2 (2024), against an average of -$0.21.
• Across the five-year window, EPS (Basic) tumbled 61.11% in 2023 and soared 44.83% in 2024, its largest moves.
• ClearPoint Neuro's EPS (Basic) stood at -$0.18 in 2022, then fell by 5.56% to -$0.19 in 2023, then retreated by 5.26% to -$0.2 in 2024, then plunged by 35.0% to -$0.27 in 2025, then retreated by 18.52% to -$0.32 in 2026.
• The last three EPS (Basic) figures came in at -$0.32 (Q1 2026), -$0.27 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.